ABERRANT GENE EXPRESSION IN HIPPOCAMPAL DENTATE GRANULE AND CA3 NEURONS IN MULTIPLE GROUPS OF SCHIZOPHRENIC PATIENTS

 

ABERRANT GENE

EXPRESSION IN HIPPOCAMPAL DENTATE GRANULE AND CA3 NEURONS IN MULTIPLE GROUPS OF

SCHIZOPHRENIC PATIENTS

 

C.A.

Altar, L. Jurata, Y. Bukhman, T.A. Young, J. Bullard H. Yokoe, A. Lemire, M.B.

Knable1 M.J. Webster2, J.A. Brockman and V. Charles

 

Psychiatric Genomics, Inc., Gaithersburg MD, 20878

1Stanley

Medical Research Institute, Bethesda, MD; 3Uniformed Services

University Health Sciences, Bethesda, MD

 

 

Several

laboratories have identified small (<50%) and mostly non-overlapping gene changes in the brains of schizophrenic patients.  These findings may be explained by the almost exclusive use of frontal cortex blocks, in which cellular heterogeneity could mask transcript changes in particular cell groups.  Hippocampal neurons were obtained using laser-capture microdissection of frozen brain sections from two cohorts, each containing normal controls and patients with schizophrenia.  One cohort also contained patients with bipolar disease or major depressive disorder.  Amplified RNA obtained from ~2000-3000 dentate granule (DG) or CA3 neurons per patient was labeled with cyanine dye and hybridized to Agilent Human 1 cDNA microarray chips.

 

Statistically significant changes in gene expression revealed by microarrays

showed 3.2 fold and 2.4 fold more gene changes than would be expected by chance

in the DG of the schizophrenics from cohorts 1 and 2, respectively (n=8 and 14)

relative to controls (n=9 and  15).  Overlaps between the cohorts in increasing

and decreasing genes of36% and 28%, respectively, were about 5- to 7-fold more

than would be expected by chance.  The fact that ~90% of the overlapping genes

changed in the same directions increases the confidence in these findings.  Gene

expression decreases outnumbered increases by 2:1, and changes were independent

of medication history, post-mortem interval, sex, pH and a variety of other

demographic factors.  Both groups of schizophrenic cohorts revealed decreases in

genes involved in synaptic transmission, neuronal signaling, vesicular and

axonal transport and neurite outgrowth.  Remarkably, 19 genes that encode for a

single macromolecular complex and 15 genes that encode for components of a

cellular organelle were also decreased, generating p values of at least 10-3

and 10-7 for each complex.

 

Many

similar gene changes were found in the CA3 neuron targets of dentate gyrus

neurons.  Some of the same genes involved in synaptic function, neuronal

signaling and vesicular transport that were decreased in schizophrenia were

significantly increased in rats (N=10/group) treated with common

antipsychotic medications.  The disease specificity of these changes was

evidenced by the finding of far fewer and mostly non-overlapping gene changes in

dentate neurons of patients with bipolar disease (n=9) or depression (n=10).

 

The

present results demonstrate the ability to isolate discrete populations of human

CNS neurons using laser-capture microdissection.  As wit studies using brain

blocks, most studies, reproducible changes in large aggregates of highly-related

genes were identified in two schizophrenia disease cohorts.  Because the

decreased expression of genes involved in synaptic structure, transmission and

transport are similar to those functions reported to be decreased in the

prefrontal cortex, such changes may contribute to the etiology of schizophrenia

and help identify potential targets for therapeutic intervention